Cargando…
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
C-reactive protein (at values ≥50 mg/L) is a useful and cheap biomarker for making antibiotic decisions in patients hospitalised for an acute exacerbation of COPD with no additional risk of adverse effect or treatment failure #AECOPD http://bit.ly/342p0Nj
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885330/ https://www.ncbi.nlm.nih.gov/pubmed/31803274 http://dx.doi.org/10.1183/20734735.0257-2019 |
| _version_ | 1783474720846381056 |
|---|---|
| author | Adepoju, Victor A. |
| author_facet | Adepoju, Victor A. |
| author_sort | Adepoju, Victor A. |
| collection | PubMed |
| description | C-reactive protein (at values ≥50 mg/L) is a useful and cheap biomarker for making antibiotic decisions in patients hospitalised for an acute exacerbation of COPD with no additional risk of adverse effect or treatment failure #AECOPD http://bit.ly/342p0Nj |
| format | Online Article Text |
| id | pubmed-6885330 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68853302019-12-04 Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? Adepoju, Victor A. Breathe (Sheff) Expert Opinion C-reactive protein (at values ≥50 mg/L) is a useful and cheap biomarker for making antibiotic decisions in patients hospitalised for an acute exacerbation of COPD with no additional risk of adverse effect or treatment failure #AECOPD http://bit.ly/342p0Nj European Respiratory Society 2019-12 /pmc/articles/PMC6885330/ /pubmed/31803274 http://dx.doi.org/10.1183/20734735.0257-2019 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
| spellingShingle | Expert Opinion Adepoju, Victor A. Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title | Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title_full | Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title_fullStr | Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title_full_unstemmed | Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title_short | Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations? |
| title_sort | can we use a biomarker to guide antibiotic treatment in severe copd exacerbations? |
| topic | Expert Opinion |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885330/ https://www.ncbi.nlm.nih.gov/pubmed/31803274 http://dx.doi.org/10.1183/20734735.0257-2019 |
| work_keys_str_mv | AT adepojuvictora canweuseabiomarkertoguideantibiotictreatmentinseverecopdexacerbations |